SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Colliers International Group, Inc. engages in the provision of commercial real estate services to corporate and institutional clients. It offers outsourcing and advisory services, lease brokerage, and sales brokerage. It operates through the following segments: Real Estate Services, Engineering, Investment Management, and Corporate. The Real Estate Services segment relates to Americas, EMEA, and Asia Pacific regions. The Engineering segment refers to engineering and project management. The Investment Management segment is involved in a global alternative asset manager with long-standing, cycle tested expertise. The Corporate segment includes the costs of global administrative functions and corporate head office. The company was founded on July 31, 1988, and is headquartered in Toronto, Canada.

Colliers International Group Inc

Colliers International Group is trending as it accelerates its strategic expansion into AI-powered innovation through a Google Cloud partnership, alongside significant acquisitions boosting its engineering and investment banking capabilities globally. The community is keenly observing how CIGI's aggressive diversification into high-value, recurring service lines will deliver growth, with many emphasizing that disciplined execution of these complex initiatives is key for investor confidence. This strategic positioning in critical growth areas highlights CIGI's push to lead in the evolving commercial real estate landscape.

Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943. The company was founded by Mark L. Smythe on August 22, 2006 and is headquartered in Newark, CA.

Protagonist Therapeutics Inc

Protagonist Therapeutics is trending amid intense market speculation of a potential acquisition by Johnson & Johnson, driven by its robust clinical pipeline. The community is actively discussing recent strong Phase 3 data for rusfertide in Polycythemia Vera and impressive Phase 2b results for icotrokinra in ulcerative colitis, which are garnering significant analyst upgrades and reinforcing bullish sentiment. These developments position PTGX as a compelling biotech M&A target with promising assets in immunology and hematology.

Cardano is a blockchain platform built on academic research that enables smart contracts and decentralized applications while using significantly less energy than traditional cryptocurrencies like Bitcoin.   What sets Cardano apart is its methodical, research-driven approach — every major feature is peer-reviewed by scientists and cryptographers before being added to the network. This careful process aims to create a more secure and stable foundation compared to platforms that prioritize speed over thorough testing. The platform's native cryptocurrency, ADA, is used to send money, pay transaction fees, and participate in network governance.  Cardano uses a proof-of-stake system to process transactions, which works differently from Bitcoin's mining approach. Instead of competing to solve complex puzzles, users can "stake" their ADA — essentially locking it up temporarily — to become validators who verify transactions. The system selects validators based on how much ADA they've staked and for how long, then rewards them with additional ADA for their participation. This approach uses far less energy than traditional mining while keeping the network secure. The platform also features a two-layer design that separates basic payment transactions from smart contract operations, allowing each function to be optimized independently for better performance.   ADA holders can earn staking rewards by locking up their tokens to help secure the network, vote on proposed changes to the platform, and use ADA for international money transfers with lower fees than traditional services.  Cardano was founded in 2017 by Charles Hoskinson, who previously helped create Ethereum. Hoskinson leads Input Output Global (IOG), the technology company that builds and maintains Cardano's core software. The ecosystem operates through three organizations: IOG handles technical development, the Cardano Foundation promotes adoption and standardization, and Emurgo helps businesses integrate blockchain technology into their operations. This structure distributes responsibilities across multiple groups rather than concentrating control in a single entity.   In February 2025, major asset manager Grayscale Investments filed to create an exchange-traded fund (ETF) for Cardano with the U.S. Securities and Exchange Commission, which would allow traditional investors to buy ADA through their regular brokerage accounts without needing to set up cryptocurrency wallets.Retry

Cardano

Cardano (ADA) is currently a hot topic, facing intense debate as a significant portion of the community labels it a "scam" and "rugpull," expressing frustration with its founder and predicting further declines. In contrast, a vocal bullish segment sees current levels as an ideal accumulation opportunity, anticipating a "parabolic bullrun" and "legendary bounce" as sentiment appears to hit despair. This polarized discussion reflects broader market anxieties, with some investors suggesting a shift of capital towards AI stocks.

World Gold Trust - SPDR Gold MiniShares Trust

GLDM is currently trending due to a surge in safe-haven demand, driven by expectations of Federal Reserve rate adjustments, global economic uncertainties, and a weakening dollar. The investment community is actively discussing gold's critical role as a robust hedge against inflation and market volatility, with many viewing GLDM as a preferred, liquid vehicle for long-term portfolio stability.

Roundhill ETF Trust - Roundhill Ether Covered Call Strategy ETF

oundhill Ether Covered Call Strategy ETF

Roundhill Ether Covered Call Strategy ETF ($YETH) is a trending topic, primarily driven by its recent shift to weekly distributions, which has garnered significant attention from income-focused investors. While community discussions reveal mixed sentiment regarding its NAV performance relative to direct Ethereum exposure, bullish long-term price predictions for Ethereum are contributing to investor interest in the ETF's potential for substantial dividends.

Ethereum Classic

Ethereum Classic ($ETC) is trending amidst intense community debate, with many users expressing frustration over its lagging performance compared to other major cryptocurrencies. Despite widespread sentiment of being "stuck" at current levels and experiencing "fake pumps," a vocal segment of the community maintains long-term bullish conviction, actively accumulating and anticipating a significant breakout. Discussions frequently revolve around its historical cycles, perceived market manipulation, and the expectation for ETC to eventually reflect broader crypto market rallies.

Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. Its products include remote patient monitoring, connectivity, and hospital automation solutions, including Masimo Patient SafetyNet, Masimo Patient SafetyNet Surveillance, Masimo SafetyNet, Masimo SafetyNet-Open, Replica, Iris, MyView, UniView, Uniview: 60, Trace, Masimo Sleep, Centroid, and Bridge. It operates through the following segments: Healthcare and Non-Healthcare. The Healthcare segment develops, manufactures, and markets a variety of noninvasive monitoring technologies and hospital automation solutions and therapeutics. The Non-Healthcare segment designs, develops, manufactures, markets and sells a broad portfolio of premium, high-performance audio products and services. The company was founded by Joe E. Kiani in May 1989 and is headquartered in Irvine, CA.

Masimo Corp

Masimo is currently trending due to a federal jury's ruling ordering Apple to pay for patent infringement related to blood-oxygen monitoring, alongside the reinstatement of an import ban on certain Apple Watch models. The community is actively discussing potential outcomes, including licensing deals or an acquisition, while also noting Masimo's recent strong earnings and strategic divestiture of its consumer audio business to sharpen its focus on healthcare innovation. Many investors are observing oversold technical indicators, anticipating a potential rebound as these developments unfold.

Modine Manufacturing Co. engages in the provision of thermal management products and solutions. It operates through the Climate Solutions and Performance Technologies business segments. The Climate Solutions segment provides climate-controlled solutions and components, heat transfer products, heating, ventilating, air conditioning and refrigeration products, and data center cooling solutions. The Performance Technologies segment designs and manufactures air- and liquid-cooled technology for vehicular, stationary power, and industrial applications. In addition, the Performance Technologies segment provides thermal solutions to zero-emission and hybrid commercial vehicle and automotive customers, and coating products and application services. The company was founded by Arthur B. Modine on June 23, 1916 and is headquartered in Racine, WI.

Modine Manufacturing Co.

Modine Manufacturing is trending as analysts issue bullish ratings and raise price targets, driven by its surging data center cooling solutions business that is capitalizing on robust demand from AI infrastructure development. The company has secured significant new orders and is expanding capacity, leading many in the community to view recent volatility as compelling buying opportunities despite some weakness in its traditional automotive markets. This positions Modine as a key, albeit often "under the radar," player benefiting from the high-performance computing mega-trend.

TOSHI

TOSHI is currently seeing a surge in community discussion, driven by robust utility developments like the upcoming Toshi Mobile launch and new DeFi tools. Increased trading volume and a dedicated holder base are reinforcing its "Face of Base" narrative, with many seeing current price levels as a significant accumulation opportunity while anticipating potential major exchange listings.

Listed Funds Trust - Teucrium 2x Long Daily XRP ETF

The Teucrium 2x Long Daily XRP ETF

The Teucrium 2x Long Daily XRP ETF ($XXRP) is trending as the crypto community eagerly anticipates the imminent launch of several spot XRP ETFs, viewing it as a leveraged play on the underlying token's potential. Investors are actively debating its amplified volatility and decay, with many accumulating shares during price dips in expectation of significant upside driven by institutional adoption and growing regulatory clarity for XRP.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Actionable Trade Alert for $GFF:

Market Context: $GFF closed at $73.25, showing a stable price within a defined range. The 60D high of $80.34 indicates potential upside, while the low of $65.01 provides a solid support level.

Directional Bias: With an RSI of 56.57, $GFF is neither overbought nor oversold, suggesting a balanced market sentiment. The current price is above the 30-day moving average (MA30) of $72.92 but slightly below the 50-day moving average (MA50) of $74.00, indicating a potential bullish reversal if it breaks above the MA50.

Trade Plan: 
- Suggested Entry: $73.50 (slightly above the last close)
- Stop Loss: $70.50 (below recent support)
- Take Profit Targets:
  1. $76.00 (4% gain)
  2. $78.00 (6.5% gain)
  3. $85.00 (16% gain)

This plan targets over 17% ROI on the third target, capitalizing on the potential upward movement within the recent high-low range.

https://privateprofiteers.com

Privateprofiteers

Private Profiteers | Elite Stock Analysis

StockTwits Web

Griffon Corp.

 closed at $73.25, showing a stable price within a defined range. The 60D high of $80.34 indicates potential upside, while the low of $65.01 provides a solid support level.

Directional Bias: With an RSI of 56.57, 

 is neither overbought nor oversold, suggesting a balanced market sentiment. The current price is above the 30-day moving average (MA30) of $72.92 but slightly below the 50-day moving average (MA50) of $74.00, indicating a potential bullish reversal if it breaks above the MA50.

Trade Plan: 
- Suggested Entry: $73.50 (slightly above the last close)
- Stop Loss: $70.50 (below recent support)
- Take Profit Targets:
  1. $76.00 (4% gain)
  2. $78.00 (6.5% gain)
  3. $85.00 (16% gain)

This plan targets over 17% ROI on the third target, capitalizing on the potential upward movement within the recent high-low range.

